My best ASX stocks to invest $2,000 in right now

Brokers sees significant value in these beaten down stocks.

| More on:
A group of businesspeople clapping.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL is trading at a significant discount, with shares down nearly 40% due to concerns over CSL Behring’s slower margin recovery and potential tariffs, but the company’s robust fundamentals and strong demand for its therapies make it appealing for long-term growth.
  • WiseTech Global has seen a rare price pullback in 2025 despite its key role in global logistics, offering a solid investment opportunity with its resilient revenue model and growing importance in an increasingly complex freight sector.
  • Both CSL and WiseTech are viewed favourably by major brokers, with substantial price targets suggesting considerable upside, highlighting the current investment potential during their market downturns.

When markets get choppy, many investors sit on the sidelines waiting for conditions to get better.

But long-term wealth is built by doing the opposite, buying high-quality stocks when uncertainty drags their share prices lower.

Right now, two ASX giants have been sold off heavily in 2025, despite continuing to strengthen their underlying businesses.

If I had $2,000 to put to work today, these ASX stocks would be at the top of my list.

CSL Ltd (ASX: CSL)

It is not often Australia's biotech champion trades at this kind of discount. CSL shares are down sharply this year, falling close to 40% from their peak as investors react to slower margin recovery at CSL Behring, uncertainty around the planned spin-off of Seqirus, and noise surrounding potential US tariffs.

But despite this, the underlying fundamentals remain strong. CSL continues to benefit from rising global demand for plasma-derived therapies, with long-term demographic and healthcare trends firmly in its favour. Its pipeline is expanding, its US manufacturing investment is progressing, and the company remains one of the most profitable and resilient healthcare businesses in the world.

Importantly, CSL's valuation has reset to levels not seen in a decade. At roughly 20x earnings, the stock is trading at a meaningful discount to its historical averages. Unsurprisingly, many major brokers now see significant upside, with price targets far above current levels.

For example, UBS has a buy rating and $275.00 price target on its shares, which implies potential upside of 50%.

WiseTech Global Ltd (ASX: WTC)

Another ASX stock that could be a great option for a $2,000 investment is WiseTech Global. It has also experienced a rare pullback in 2025, despite continuing to strengthen its position as one of the world's most important logistics software companies.

Its CargoWise platform is embedded across global supply chains, used by many of the largest freight forwarders and logistics operators across Europe, Asia and North America.

The company's recurring revenue model, sticky customer base, and history of disciplined acquisitions have made it one of the ASX's most consistent tech performers over the past decade. And with global freight complexity increasing, WiseTech's software is becoming more essential, not less.

Despite this, the share price has been volatile this year and that volatility offers an attractive entry point according to many brokers.

Morgans is one of them. It has a buy rating and $127.60 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Man holding out Australian dollar notes, symbolising dividends.
Blue Chip Shares

Where to invest $10,000 in ASX shares in December

These shares could be great picks for Aussie investors this month.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

These are the top ASX blue-chip shares I'd buy today

I believe these large stocks still have significant growth potential.

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Blue Chip Shares

3 ASX stocks I'd trust with $10,000 for the next decade

Let's see why these blue chips could be great long term picks for investors.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Blue Chip Shares

These top ASX 200 stocks could rise 25% to 60%

These shares could be cheap at current levels according to analysts.

Read more »

Two brokers analysing stocks.
Blue Chip Shares

Why are QBE shares sinking 6% today?

Let's see how the insurance giant is performing in FY 2025.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Blue Chip Shares

Buy low candidates: Two of the worst-performing ASX 200 stocks this year

Looking for undervalued stocks? Here are two to consider.

Read more »

a couple look dumbfounded with exaggerated looks of surpirse on their faces as te mman holds a phone in his hand.
Blue Chip Shares

Why this ASX 100 stock could rocket 46%

This blue chip is being tipped to rise strongly by a leading broker.

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Blue Chip Shares

Top Australian stocks to buy right now with $5,000

Let's look at three shares that could be among the best to buy now.

Read more »